» Advanced search
Only first 10,000 results will be saved in the file.
No item is selected. Use checkboxes to select search results.
Displaying 826-834 of 834 results.
 
{{ selectedCountPage }} items selected on this page, {{ selectedCountPage }} item selected on this page, {{ selectedCountTotal }} item in total {{ selectedCountTotal }} items in total
The main target of this study is to assess the safety and efficacy of β-D-Mannuronic acid in patients suffering from Rheumatoid Arthritis. Β-D-Mannuronic acid which is an anti-inflammatory agent, is ranked in the family of nonsteroidal anti-inflammatory drugs. This agent has expressed qualified therapeutic effects with the greatest tolerability and safety in different experimental models like experimental model of Multiple schlerosis, Rheumatoid arthritis, nephrotic syndrome and acute glomerulonephritis. In this randomized controlled trial, 203 patients afflicted by Rheumatoid Arthritis, diagnosed based on the American College of Rheumatology (ACR) Diagnostic Criteria that have active disease, will be examined. Furthermore, these patients should not have other concomitant diseases such as Hepatic, renal, cardiovascular diseases or malignancies. Written informed consent will be signed by the patients. Then Patients will be randomly divided into two groups (Treatment and Control group). Treatment group (112 patients) will receive β-D-Mannuronic acid 1500 mg/day (three 500 mg tablets/day)with conventional immunosuppressive drugs and Control group (91 patients) ) will receive placebo with conventional immunosuppressive drugs orally for 12 weeks. Medical history and clinical parameters including the serum level of CRP, ESR, RF and Anti CCP will be evaluated at baseline and 12 weeks after treatment. The manner of blinding in this study is so neither participants in the study nor the persons who perform the test will be aware of the intervention. In order to allocate the patients randomly into two groups mentioned above, at first 29 blocks of 7 with C and T letters (The letters indicate the Treatment and Control groups) are created. 4 patients of each block belong to the treatment group and 3 patients belong to the control group. Then the blocks are randomly selected and arranged to reach a sequential combination of 203 letters. Each letter will be placed in a sealed packet according to the obtained sequence
IRCTID: IRCT2017100213739N10
  1. A randomized controlled trial comparing the effects of β-D-Mannuronic acid and immunosuppressive drugs on disease activity and inflammatory markers in patients with Rheumatoid Arthritis
  2. Evaluation of the effect of Beta-D mannuronic acid on processing of breast cancer disease
  3. A randomized controlled trial comparing the effects of β-D-Mannuronic acid and conventional Non-steroidal anti-inflammatory drugs on disease activity and inflammatory markers in patients with ankylosing spondylitis
  4. Comparing the effects of α-L-Guluronic acid with conventional Non-steroidal anti-inflammatory drugs on disease activity and inflammatory markers in patients with Rheumatoid Arthritis
  5. Comparing the effects of β-D-Mannuronic acid with Placebo in Myelodispelasia patients and related clinical and paraclinical parameters before and after treatment
  6. A randomized controlled trial of β, D, Mannuronic acid compared with interferon,beta on clinical signs and symptoms and magnetic resonance imaging (MRI) in multiple sclerosis patients
  7. Therapeutic Efficacy of Urtica dioica and Evening Primrose in Patients with Rheumatoid Arthritis: A Randomized Double-Blind, Placebo-Controlled Clinical Trial
  8. A study on the effect of chia seed intake inflammatory markers, joint pain severity, body weight and quality of life in patients with rheumatoid arthritis
  9. Pilot evaluation of the anti-inflamation and analgesics effect of oral administration of Melissa officinalis in patients with Rheumatoid arthritis: a double-blind randomized crossover trial
  10. Evaluating the effect of anti-inflammatory diet and flax seed on disease activity, inflammatory factors and quality of life in rheumatoid arthritis patients
Study aim: Determination of the effectiveness of melatonin-containing mucoadhesive on minor recurrent aphthous stomatitis Design: A clinical trial with a control group, with parallel groups, double-blind, randomized, phase 3 on 44 patients. Random allocation software 2 for randomization. Settings and conduct: Toouba Dental Clinic, Mazandaran University of Medical Sciences How to intervene in the intervention group (with melatonin mucosal adhesive) and control (placebo): Mucosal adhesive 3 times a day (Morning, afternoon and night) for 30 minutes and removing then (In addition to the examination on the day of visit), the patient should revisit on the third, fifth, and seventh days to have the pain level with the Visual analogue scale, the size of the ulcer with the probe, as well as the length of the healing period In this double-blind study (researcher, analyst and participant) for blinding, codes A (melatonin) and B (placebo) will be generated using software. Finally, the codes will be placed in a sealed envelope and the sample number will be written on the envelope. These envelopes, along with the mucosal adhesive, will be in dark packaging with the same color and shape. Participants/Inclusion and exclusion criteria: Inclusion: Men and women aged 18 to 50 years, with aphthous lesions (up to 48 hours from the formation of the lesion, with a size less than 10 mm and a diameter greater than 2 mm), lesions of the lips and buccal mucosa Exclusion: pregnancy or lactation, ulcers as a manifestation of a systemic disease, use of non-steroidal anti-inflammatories, opioids, immunomodulatory agents, and analgesics Intervention groups: 3 pieces of mucosal adhesive will be glued daily (a total of 21), use for 30 minutes (without eating or drinking at the time of use) and removing then by patient Main outcome variables: pain; size of the lesion
IRCTID: IRCT20240712062408N1
Study aim: Determining the effectiveness of oral allicin tablets on minor recurrent aphthous stomatitis Design: Controlled clinical trial, with parallel groups, unblinded, randomized, phase 3 on 60 patients. Randomization with random allocation software 2 Settings and conduct: Touba Dental Clinic, Mazandaran University of Medical Sciences Intervention method: In the intervention group (with oral allicin tablets) and control (placebo): 4 tablets (every 6 hours) daily (In addition to the examination on the day of referral), the patient must return on the third, seventh, and tenth days to assess the pain level with a visual analog scale, the size of the wound with a probe, and the length of the healing period. In this study, due to the garlic smell of the allicin-containing tablets, blinding will not be performed and the tablets will be provided to the patients after randomization. Participants/Inclusion and exclusion criteria: Inclusion criteria: Men and women aged 18 to 50 years; patients with aphthous lesions on the lips, buccal mucosa, floor of the mouth and tongue; maximum 48 hours have passed since the lesion formation. Exclusion criteria: Allergy to allicin; pregnancy or lactation; ulcer as a manifestation of a systemic disease such as Behçet's disease, ulcerative colitis, Crohn's disease or acquired immunodeficiency; use of non-steroidal anti-inflammatory drugs, narcotics, immunomodulating agents; systemic antibiotics use in the 2 weeks prior to study entry; the patient has a bleeding disorder Intervention groups: The intervention group will receive oral allicin tablets (400 mg, Dineh, Iran) containing 1100 micrograms of allicin, and the control group will receive placebo. The patient will take 4 allicin tablets (every 6 hours) (4.4 mg daily) for 10 days. Main outcome variables: Pain level; Ulcer size; Healing period
IRCTID: IRCT20241208063988N1
Study aim: Determining the effectiveness of ibuprofen-containing mucoadhesive on minor recurrent aphthous stomatitis Design: Controlled clinical trial, with parallel groups, double-blind, randomized, phase 3 on 44 patients, Randomization with random allocation software 2 Settings and conduct: Touba Dental Clinic, Mazandaran University of Medical Sciences Intervention method in the intervention group (ibuprofen) and control (placebo): Use of mucusal adhesive 3 times a day for 30 minutes (without eating or drinking during use) (In addition to the examination on the day of visit), the patient must return on the third, fifth and seventh days to check the pain level with a visual analog scale, the size of the wound with a probe In this double-blind study (researcher, analyst and participant) for blinding, codes A (ibuprofen) and B (placebo) will be generated using software. Finally, the codes will be placed in a sealed envelope and the sample number will be written on the envelope. These envelopes, along with the adhesive mucus, will be in dark packaging with the same color and shape. Participants/Inclusion and exclusion criteria: Inclusion: Men and women 18 to 50 years of age; having aphthous ulcers (within 48 hours of lesion formation, with a size smaller than 10 mm); aphthous lesions on the lips and buccal mucosa Exclusion: Pregnancy or lactation; ulcers as a manifestation of a systemic disease; taking nonsteroidal anti-inflammatory drugs, narcotics, immunomodulators, analgesics; people with diseases such as active gastrointestinal or cerebrovascular bleeding, uncontrolled heart failure, lupus, renal failure and liver failure or disease Intervention groups: In the intervention and placebo groups, the medication will be applied 3 times daily (the patient should refrain from eating and drinking for 30 minutes during use). Main outcome variables: Pain level; Ulcer size
IRCTID: IRCT20241208063987N1
Study aim: To investigate the effectiveness of extremely low frequencies (ELF) electromagnetic fields in the treatment of drug-resistant E. Coli-induced chronic bacterial cystitis. Design: Two-arm, parallel group, double blind randomized controlled clinical trial Settings and conduct: The study will be conducted in ID MEDICALS Moretti Roma, Italy Participants/Inclusion and exclusion criteria: Women, age 18 to 80 years, suffering from chronic E-coli indued drug-resistant cystitis will be recruited. Women with serious co-morbid conditions will be excluded. Intervention groups: Experimental group: Experimental group will receive electromagnetic fields, modulated at extremely low frequencies . For treatment, a sequence of signals (BSB) will be created. In order to emit the BSB sequence, a PEMF ion resonance generator, Seqex (SISTEMI SRL) mod MED (compliant with Directive 93/42/EEC and standard EN 60601-1 regarding safety and essential performance, CE Certificate issued by Notified Body CE0051), will be used. This can write signal sequences, store them on a card, and emit them, emitting sequences from 1 to 80 Hz, with 30 waveforms, and signal intensity from 1 to 100 µT at the source. A total of 8 applications will be performed, twice a week with a 48-72 hour interval between each session (i.e., Monday and Thursday). Control group: The control group will receive placebo. Placebo will be used by placing the applicators without emitting signals, thus patients will have no idea whether they are in the experimental group or control group. Main outcome variables: All participants will be tested for IL-6 and D-dimer (from a complete blood count), urine analysis (pH, specific gravity, urobilinogen, red blood cells, and leukocytes), and urine culture, detecting E. coli at levels greater than 100,000 CFU/ml.
IRCTID: IRCT20211022052833N3
  1. Investigation of Resonance Effect Caused by Exposure of Local extremely low frequency Magnetic Field on Brain Signals
  2. Evaluation of Extremely Low Frequency Electromagnetic Fields Effects on Oxidative Stress and Reducing the effects of Oxidative Stress by Intervention of Vitamin E and C in Shaheed Bastami Power Plant’s Workers; A Duble Blind, Randomized Clinical Trial Study
  3. Design and implement of emotion recognition system based on dynamic adaptive fusion of forehead biopotentials and physiological signals
  4. Acute toxicity and dose constraints of organs at risk in Fast Forward radiotherapy in early stage breast cancer by Tomotherapy and Intensity-Modulated radiation therapy(IMRT)
  5. Clinical Trial to Comparison of Fracture Healing between Closed Reduction Surgery Alone and in Combination with Pulsed Magnetic Filed in Patients with Mandibular Fracture
  6. Music-induced emotion recognition based on information fusion of forehead biopotentials and acoustic content in healthy women
  7. Investigating the effect of pulsed electromagnetic field on pain intensity and function of patients with spinal stenosis compared to the control group referring to physical medicine clinics: A randomized controlled clinical trial study
  8. Comparison the effects of Acetaminophen and Ibuprofen on emotions by recording electrical activity of the brain
  9. Comparing the effect of bright light and not having bright light on circadian rhythm changes of temperature and melatonin and fatigue in shift worker nurses
  10. Evaluating the rate of complete clinical response following total neoadjuvant therapy by using chemoradiotherapy by Intensity modulated radiation therapy with simultaneous integrated boost (IMRT-SIB) in patients with lower rectal cancer; a Phase II randomized clinical trial
osseodensification drilling (Charisma kit, Pakistan) and the contralateral side conventional drilling (DIO kit, South
IRCTID: IRCT20260124068649N1
Study aim: The aim of this study is to compare the effects of Terminalia chebula extract and Terminalia chebula powder combined with oat powder versus placebo on glycemic control indices and lipid profile in individuals with prediabetes. Design: This study is a randomized, placebo-controlled, three-arm, parallel-group, single-blind clinical trial conducted among 75 participants with prediabetes typ 2 Settings and conduct: This randomized, placebo-controlled, three-arm, parallel, single-blind clinical trial will be conducted among 75 individuals with prediabetes at the 501 Army Hospital in Tehran. Participants will be randomly assigned to receive placebo, black myrobalan (Terminalia chebula) powder, or black myrobalan extract, with the latter two formulations combined with oat powder. They will consume one 6-g sachet daily for 6 weeks. Blood glucose and lipid profiles will be assessed before and after the intervention. Participants/Inclusion and exclusion criteria: Diagnosis of type 2 prediabetes prior to enrollment in the study Fasting blood glucose greater than 100 and less than 125 Age between 18 and 70 years Willingness to participate in the study and signing of the informed consent form Intervention groups: Control group (placebo): Participants receive one 6-g sachet of a placebo daily, matched in appearance and taste, with minimal potential effects on glycemic and lipid parameters. Intervention group 1: Participants receive one 6-g sachet daily containing Terminalia chebula powder and oat powder. Intervention group 2: Participants receive one 6-g sachet daily containing Terminalia chebula extract and oat powder. Main outcome variables: Primary outcomes The primary outcomes of the study were: Fasting blood sugar (FBS) Fasting insulin Insulin resistance index (HOMA-IR) The insulin resistance index was calculated based on fasting blood sugar and fasting insulin values.
IRCTID: IRCT20260822070751N1
  1. Evaluating the effect of black myrobalan fruit (Terminalia Chebula Retz.) on cognitive impairments, and positive and negative symptoms in patients with chronic schizophrenia
  2. Evaluating the effect of Myrobalan (Terminalia Chebula.) cream, 5% compared to hydroquinone cream, 2% in the treatment of melasma
  3. The Combined effect of high-intensity functional training and terminalia chebula extract on liver enzymes, metabolic syndrome indices, and physical fitness factors in women with metabolic syndrome
  4. The Effect of High-Intensity Functional Training Combined with Terminalia chebula Supplementation on Nitric Oxide, C-Reactive Protein, Insulin Resistance, and Cardiometabolic Risk in Women with Metabolic Syndrome
  5. Evaluation of effect of Terminalia chebula fruit, Commiphora myrrh and Commiphora mukul oleo-gum-resin mixture on glycemic control and lipid profile in type 2 diabetic patients with hyperlipidemia: A double blind, randomized, placebo controlled clinical trial.
  6. The effect of a capsule prepared from the aqueous extract of Terminalia Chebula on catatonia in patients with Parkinson's disease
  7. Effect of Terminalia chebula gel in reducing the pain of patients with knee osteoarthritis: triple-blind randomized clinical trial
  8. Evaluating the effect of Terminalia chebula, Pistacia lenticus and brown sugar oral preparation onrespiratory clinical findings and inflammatory indicators in patients with COVID-19
  9. Evaluation of Terminalia chebula extract in preventing contrast media-induced nephrotoxicity
  10. Terminalia chebula Therapeutic effects in Patients With Symptomatic Hemorrhoids in reducing hemorrhage
Karachi, Pakistan population referred to physiotherapy clinic. Before and after 6 weeks interventions
IRCTID: IRCT20130121012210N10
  1. Comparing electromyographic changes, pelvic tilt and back strength in chronic low back pain sufferers with tight hamstring muscle in stretching exercise group and strength exercise in lengthened position group. A randomized controlled clinical Trial
  2. Comparing the effects of muscle energy techniques (post isometric relaxation and reciprocal inhibition) on hamstring tightness and anterior pelvic tilt with knee osteoarthritis: A randomized clinical trial
  3. Comparison of the immediate effect of self-release, static stretching and Graston technique in the Iliotibial band and tibialis anterior muscle on the range of motion and proprioception of the neck of athletes
  4. Immediate effect of soft tissue mobilization tool (Graston), static hold-relax, and muscle energy techniques on hamstring muscle shortness in healthy athletes: Randomized clinical trial
  5. The Effects of Myofascial Release and Stretching of the Hamstring and Plantar Fascia on Range of Motion, Cervical Proprioception, Static and Dynamic Balance, Muscle Strength, and Jump Performance
  6. Comparative Effects of Proprioceptive Neuromuscular Facilitation and Muscle Energy Technique of Iliopsoas Muscle on Non-Specific Low Back Pain
  7. Comparison of the Effects of Iliopsoas Strain-Counterstrain Technique and McKenzie Exercise Therapy on Directional Preference in Patients with Chronic Non-Specific Low Back Pain
  8. Investigating the Effect of Combined Exercise Training on Low Back Pain Severity in Pregnant Housewives
  9. The effect of combined pelvic floor treatments on sexual function, pelvic floor muscle strength and endurance in women with chronic low back pain at two different levels of fear of pain
  10. Comparison of the metabolic factors in obese patients’ pre and post bariatric surgery after 3 months trial of aerobic versus strengthening exercises
Study aim: Comparison of the Effects of Demineralized Dentin Graft and Freeze-Dried Bone Allograft on Bone Dimensional Changes and Soft Tissue Thickness in Alveolar Ridge Preservation Design: A two-arm, parallel-group randomized clinical trial involving 16 patients, randomized using permuted block randomization with variable block sizes of 4 and 6. Settings and conduct: This is a two-arm, parallel-group randomized clinical trial to be conducted at the School of Dentistry, Guilan University of Medical Sciences. Patients will be allocated to two groups for ARP: FDBA and DDG. In the DDG group, an extracted third molar will be used to prepare the graft material by grinding it with a hand-operated bone mill. The prepared graft will be placed in the extraction socket and covered with an absorbable collagen membrane. CBCT scans and soft tissue thickness measurements will be obtained before ARP and four months afterward. DIO implants will be placed four months after the intervention. The outcome assessor and data analyst will be blinded to treatment allocation. Participants/Inclusion and exclusion criteria: Inclusion Criteria - Age ≥ 18 years. - Presence of a non-restorable maxillary premolar and a non-restorable maxillary third molar. - Extraction sockets with less than 50% buccal bone loss. Exclusion Criteria - Presence of acute or chronic infection or local pathology at the intended grafting site. - Presence of parafunctional habits. - Implant placement limitations - Use of medications that may interfere with bone healing - History of uncontrolled systemic diseases or conditions that may interfere with bone healing Intervention groups: 1. Demineralized Dentin Graft (DDG) Group 2. Freeze-Dried Bone Allograft (FDBA) Group Main outcome variables: Reduction in alveolar ridge width (mm). Soft tissue thickness before ARP and four months after ARP. Need for additional interventions before implant placement.
IRCTID: IRCT20221024056284N2
  1. The clinical , histological and histomorphometrical comparison of the effect of decalcified friezed – dried bone allogenic graft with platelet rich plasma for alveolar ridge preservation post extraction.
  2. Clinical, Histologic and histomorphometric evaluation of Bone Strip Allograft with resorb able membrane in horizontal alveolar ridge augmentation
  3. Clinical and histologic comparision of alveolar ridge preservation following tooth extraction using DFDBA & Bio – oss
  4. The comparison between autogenous tooth and autogenous bone graft for phenotype modification around immediate implants
  5. Effect of Buccal Fat Pad Derived Mesenchymal Stem Cells Loaded on Allograft with Platelet-rich Plasma in Maxillary Sinus Augmentation
  6. The Effect of Allogenic Demineralized Dentin Matrix (ADDM) on healing outcome in maxillary sinus floor augmentation (Histological and Radiological examination):Clinical trial
  7. Comparison of histological and radiological effect of FDBA with and without autogenous bone graft with collagen membrane in horizontal augmentation of alveolar bone
  8. Comparative evaluation of papilla reconstruction between adjacent implants using bone and connective tissue graft in patients referring to Periodontics Department of Hamadan School of Dentistry
  9. Comparison between acellular dermal matrix and connective tissue graft on vertical soft tissue thickness during submerged implant insertion
  10. Acellular dermal matrix loaded with zinc oxide nanoparticles as a new membrane in extraction socket preservation technique: a clinical and CBCT study
Loading...